ArticleTranslational andrology and urology2025
Association of visceral adiposity index and overactive bladder: insights from NHANES 2007-2018.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the exploration of the pathogenesis of overactive bladder (OAB), emerging evidence suggests a potential link between OAB and obesity. However, the association between visceral fat accumulation and OAB has not been definitively established. The aim of the study is to analyze and establish the relationship between visceral adiposity index (VAI) and OAB in large population studies. Methods: The study included 13,694 participants from the National Health and Nutrition Examination Survey (NHANES) database covering the years 2007 to 2018. VAI was calculated using waist circumference (WC), body mass index (BMI), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-c). OAB was defined via the Overactive Bladder Symptom Score (OABSS ≥3). It utilized weighted multivariable logistic regression to analyze the association between VAI and OAB, as well as the relationship between the two across various subgroups. Additionally, restricted cubic spline (RCS) analysis was employed to explore the nonlinear relationship between VAI and OAB. Results: Weighted multivariable logistic regression indicated a significant association between VAI and OAB (P<0.05). After adjusting for covariates, a notable association was found between the "Q4" of VAI and the occurrence of OAB (all P<0.05). Subgroup analysis results were consistent with those of the overall population (P for interaction >0.05). RCS revealed a nonlinear positive dose-response relationship (P<0.001), with a significant inflection point at VAI =1.41. Conclusions: The study identified a nonlinear positive dose-response relationship between VAI and the occurrence of OAB. Incorporating VAI into comprehensive management strategies for OAB is a meaningful exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.